Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.

Condition:   Diarrhea Interventions:   Drug: DWJ1230;   Drug: DWB2001 Sponsor:   Daewoong Pharmaceutical Co. LTD. Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials